Pennsylvania lawmakers have reopened the debate over legalizing recreational marijuana as the Commonwealth finds itself increasingly surrounded by states operating regulated adult-use cannabis markets. On September 25, 2026, the Pennsylvania Senate Democratic Policy Committee held a hearing examining the criminal justice, public-safety and economic effects of adult-use cannabis legalization, bringing together prosecutors, cannabis-policy specialists, industry representatives and people with experience operating in other legal states. The hearing was hosted by committee chair Sen. Nick Miller alongside Sen. Sharif Street, who has worked on cannabis legislation across several legislative sessions.
One of the central issues raised during the hearing was the growth of legal cannabis markets immediately surrounding Pennsylvania. Dr. Oren Gur, director of research and the DATA Lab for the Philadelphia District Attorney’s Office, presented lawmakers with data on the regional market and argued that Pennsylvania residents now live in a state largely surrounded by legal adult-use cannabis. New York, New Jersey, Maryland, Delaware and Ohio all allow recreational marijuana sales, while West Virginia remains the only Pennsylvania border state without an adult-use market. Estimates discussed during the hearing put combined recreational marijuana sales in neighboring states at close to $5 billion, intensifying questions about consumer spending, tax revenue and whether Pennsylvania’s existing prohibition remains practical in a region where legal marijuana is widely available.
Pennsylvania Is Becoming an Island in a Regional Legal Cannabis Market
The transformation around Pennsylvania has occurred quickly. New Jersey began recreational sales in 2022, Maryland followed in 2023, Ohio launched adult-use sales in 2024, Delaware began sales in 2025 and New York has continued rapidly expanding a market that initially struggled with its rollout. Together, those markets now represent billions of dollars in annual legal cannabis transactions. Pennsylvania residents near Philadelphia, the Lehigh Valley, Erie and other border regions may live within relatively short driving distance of legal marijuana retailers operating in neighboring states.
That regional reality has become a major part of the legalization argument. Supporters contend that keeping recreational sales prohibited does not necessarily prevent Pennsylvania residents from obtaining marijuana; instead, it can redirect purchases to neighboring states or unregulated suppliers. Opponents counter that easy access outside Pennsylvania is not, by itself, a sufficient reason to legalize and argue that policymakers must also consider impaired driving, adolescent exposure, high-potency products and other public-health concerns before creating another commercial intoxicant market. The September hearing was structured specifically to examine those competing criminal-justice, safety and economic questions rather than treating legalization solely as a revenue proposal.
Pennsylvania Has Already Come Closer to Legalization Than Ever Before
The renewed Senate discussion comes after Pennsylvania’s House of Representatives made history in 2025 by approving an adult-use marijuana bill for the first time. House Bill 1200 passed the House 102-101 on May 7, 2025, an extraordinarily narrow margin that demonstrated both how far legalization had advanced and how divided lawmakers remained. The legislation would have established Pennsylvania Cannabis Stores through the state Liquor Control Board and created rules governing testing, packaging, taxation, equity programs and the treatment of past marijuana convictions.
The proposal stalled almost immediately after reaching the Senate. On May 13, the Senate Law and Justice Committee voted 7-3 against reporting the legislation, effectively ending that particular approach. The disagreement was not simply between lawmakers who supported legalization and those who opposed it. Some senators who favor legal adult-use cannabis objected specifically to the House proposal’s state-operated retail system, preferring private licensed businesses rather than government-run marijuana stores. That split over market structure remains one of the biggest obstacles to reaching a final compromise.
A Bipartisan Senate Legalization Plan Takes a Different Approach
Republican Sen. Dan Laughlin and Democratic Sen. Sharif Street responded to the collapse of the House bill by introducing Senate Bill 120 in July 2025. Their proposal would establish a privately operated, state-regulated recreational marijuana market overseen by a newly created Pennsylvania Cannabis Control Board. Adults 21 and older would be permitted to purchase cannabis from licensed businesses, while the board would regulate cultivation, processing, retail sales, laboratory testing, advertising, product labeling and seed-to-sale tracking.
Existing medical marijuana businesses could seek adult-use licenses, but the proposal also calls for opportunities for new companies, including small businesses and applicants from communities disproportionately affected by marijuana enforcement. The legislation includes age-verification requirements, restrictions on advertising aimed at minors, product-testing standards and provisions allowing employers to maintain drug-free workplace policies. Revenue would be divided among programs involving public safety, medical cannabis assistance, prevention, workforce development, equity initiatives and the state General Fund.
SB 120 also includes a cannabis Clean Slate provision intended to clear qualifying nonviolent marijuana records. Despite being sponsored by lawmakers from both parties, the legislation has not received a Senate floor vote. It was referred to the Senate Law and Justice Committee in July 2025, and a resolution seeking to discharge the bill from committee was introduced on June 29, 2026. As of late September, the General Assembly’s official record shows no committee vote moving SB 120 forward.
State Analysts See Hundreds of Millions in Potential Revenue
The economic stakes extend beyond spending currently flowing to neighboring states. Pennsylvania’s Independent Fiscal Office analyzed Gov. Josh Shapiro’s recreational marijuana proposal in February 2026 and estimated that legalization could eventually produce hundreds of millions of dollars annually for the state General Fund. The governor’s framework calls for a 20 percent wholesale excise tax on recreational marijuana, while retail purchases would also be subject to Pennsylvania’s 6 percent sales and use tax.
Under the IFO model, the net General Fund impact would be approximately $140 million in fiscal year 2026-27, assuming license activity began in July 2026 and recreational sales started in January 2027. The estimated benefit would rise to $284 million the following year, $409 million in fiscal 2028-29, $422 million in 2029-30 and roughly $432 million by 2030-31. These figures are projections rather than guaranteed revenue. The IFO based its estimate partly on spending patterns in comparable legal states and assumptions about how quickly Pennsylvania’s own market would develop.
The analysis illustrates why cannabis has become a significant budget issue, but tax rates also create a policy tradeoff. Higher taxes generate more revenue on every legal sale, while potentially increasing the price difference between licensed products and cannabis sold through the illicit market. States that have legalized marijuana have taken widely different approaches to excise taxes, with regulators attempting to balance revenue generation against the goal of moving consumers into a tested and regulated marketplace.
Criminal Justice Remains Central to the Debate
The September Senate hearing was not designed only around tax collections. Its agenda specifically included criminal justice, enforcement and public-safety considerations, and witnesses included representatives from the Philadelphia District Attorney’s Office as well as former Warren County District Attorney Robert Greene. Cannabis-industry and policy organizations also participated, including the Cannabis Coalition of Pennsylvania, the American Trade Association for Cannabis and Hemp and the Marijuana Policy Project. Representatives with experience in Maryland’s legal market were invited to discuss lessons from another nearby state.
Criminal-record relief has become a recurring feature of Pennsylvania legalization proposals. Both HB 1200 and SB 120 include provisions addressing prior marijuana convictions or expungement. Supporters of those provisions argue that continuing to burden people with low-level marijuana records after the conduct becomes legal would create an inconsistent system. Others have urged lawmakers to ensure that expungement rules distinguish between simple possession and more serious conduct and that police retain clear authority over unlicensed commercial sales, impaired driving and sales to minors.
Public Safety Could Determine the Final Shape of Legalization
Any legalization legislation would also have to address cannabis potency, testing standards and impaired driving. Modern marijuana products can contain substantially higher concentrations of THC than cannabis commonly available decades ago, while concentrates and edible products create different dosing and impairment concerns than traditional marijuana flower. States with regulated markets have responded with testing, labeling, serving-size requirements and restrictions on packaging designed to appeal to children.
Supporters of regulation argue that those risks are reasons to establish a controlled legal market rather than leave cannabis sales outside the regulated system. Critics argue that commercialization could increase product availability and normalize use, particularly among younger consumers. Pennsylvania lawmakers therefore face a policy choice involving not simply whether marijuana should be legal, but what rules would govern potency, marketing, retail density, packaging, taxation and enforcement if legalization moves forward.
Pennsylvania Already Has a Mature Medical Cannabis Industry
Pennsylvania would not be building a cannabis regulatory system entirely from scratch. The state legalized medical marijuana in 2016 and now has an established network of licensed growers, processors and dispensaries serving registered patients. That infrastructure gives Pennsylvania existing experience with product testing, inventory tracking, security rules and regulated cannabis distribution.
The presence of established medical operators also creates another difficult policy question: how much access should existing cannabis companies receive to a future recreational market? Allowing medical operators to transition rapidly into recreational sales could help Pennsylvania launch a regulated market quickly. But lawmakers have also raised concerns that giving existing operators too great an advantage could limit competition and reduce opportunities for independent businesses and applicants from communities affected by marijuana prohibition. SB 120 attempts to address both concerns by allowing existing operators to participate while also creating opportunities and financial assistance for new entrants.
Intoxicating Hemp Products Add Another Layer to the Issue
Pennsylvania’s marijuana debate is occurring alongside a separate but related problem involving hemp-derived intoxicants. Products containing delta-8 THC, THCA and similar cannabinoids have become widely available in smoke shops, convenience stores and online even though they are not regulated through Pennsylvania’s medical marijuana program.
That has complicated the argument that the Commonwealth currently operates under a simple prohibition model. Consumers can encounter intoxicating cannabinoid products through loosely regulated channels even while conventional recreational marijuana remains illegal. Lawmakers have consequently discussed stronger testing, age-verification and labeling standards for hemp products at the same time they debate whether to create a comprehensive recreational cannabis system. A future adult-use law would therefore have to fit into a cannabinoid marketplace that already exists rather than create one from nothing.
The Main Question Is Increasingly What Legalization Would Look Like
Pennsylvania’s political landscape surrounding cannabis has changed considerably over the past several years. The House has demonstrated that a legalization bill can obtain majority support, the Senate has a bipartisan private-market proposal, and the governor has repeatedly incorporated recreational cannabis into his budget plans. At the same time, there remains no agreement between the chambers on the fundamental structure of the market.
The House’s 2025 model relied heavily on state-operated cannabis stores. The Laughlin-Street proposal relies on privately licensed retailers overseen by an independent regulatory board. Tax rates, business licensing, equity programs, criminal-record relief and the transition of existing medical marijuana companies remain additional points of negotiation. HB 1200’s narrow 102-101 House vote and subsequent 7-3 defeat in a Senate committee illustrate how little room lawmakers have for disagreement if a bill is ultimately going to pass both chambers.
Nearly $5 Billion in Neighboring Sales Adds Pressure, Not Certainty
The regional sales figures highlighted at the September hearing provide a powerful backdrop to the discussion but do not determine Pennsylvania’s policy. Neighboring states have demonstrated that regulated cannabis markets can generate billions of dollars in consumer spending, while Pennsylvania’s own fiscal analysts estimate a mature market could eventually contribute more than $400 million annually to the General Fund under one proposed tax structure.
At the same time, legalization involves questions extending well beyond revenue: how to regulate high-potency products, discourage underage use, address impaired driving, compete with unlicensed sellers, structure business ownership and handle marijuana convictions imposed under previous law. Those issues are why the Senate’s latest hearing focused simultaneously on economic effects, criminal justice and public safety.
For now, adult-use marijuana remains illegal in Pennsylvania, and neither SB 120 nor another legalization proposal is assured of advancing. What has changed is the environment in which lawmakers are making that decision. Pennsylvania now sits almost entirely inside a regional network of legal recreational marijuana markets, while its own residents, businesses and state government remain outside that system. The September hearing places that reality back before lawmakers as they consider whether Pennsylvania should maintain its current approach or design an adult-use market of its own.
